Threshold Pharmaceuticals Presents Positive Preclinical Results at International Myeloma Workshop
May 03, 2011 16:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., May 3, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced a presentation of preclinical research on its clinical stage hypoxia-activated...
Threshold Update Since Sudden Death of Its Chief Medical Officer
April 25, 2011 08:30 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 25, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today provided an update since the death last week of John G. Curd, M.D., president and chief...
Threshold Announces Unexpected Death of Its Chief Medical Officer
April 21, 2011 08:30 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 21, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced the death of John G. Curd, M.D., president and chief medical officer. Dr. Curd...
Threshold Announces Presentation and Webcast at BioCentury Future Leaders Conference
April 12, 2011 16:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 12, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold's chief executive officer, is scheduled to...
Threshold to Present at Needham Healthcare Conference
April 04, 2011 16:00 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold's chief executive officer, will present at the...
Threshold Pharmaceuticals Presents TH-302 Translational Data in Three Scientific Presentations at AACR Annual Meeting
April 04, 2011 08:35 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced multiple preclinical presentations on its clinical stage hypoxia-activated...
Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results
March 24, 2011 08:35 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., March 24, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today reported financial results for the fourth quarter and the year ended December 31,...
Threshold Pharmaceuticals Completes $30 Million Registered Direct Offering
March 17, 2011 08:35 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., March 17, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced the completion of its previously announced registered direct offering of common...
Threshold Pharmaceuticals Announces Registered Direct Offering of $30 Million
March 11, 2011 09:21 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., March 11, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced that it has agreed to sell approximately $30 million of its common stock and...
Threshold Pharmaceuticals Announces Agreement With the FDA on a Special Protocol Assessment for Planned Phase 3 TH-302 Combination Trial in Advanced Soft Tissue Sarcoma
February 16, 2011 08:30 ET
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., Feb. 16, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that the Company reached agreement with the U.S. Food and Drug Administration...